These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39128058)

  • 1. Prognostic Value of S100 Family mRNA Expression in Hepatocellular Carcinoma.
    Wan R; Tan Z; Qian H; Li P; Zhang J; Zhu X; Xie P; Ren L
    Turk J Gastroenterol; 2024 Apr; 35(4):316-334. PubMed ID: 39128058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma.
    Zheng S; Liu L; Xue T; Jing C; Xu X; Wu Y; Wang M; Xie X; Zhang B
    Front Genet; 2021; 12():648156. PubMed ID: 33815482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
    Zhang Q; Xia T; Qi C; Du J; Ye C
    BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic values of S100 family members in ovarian cancer patients.
    Bai Y; Li LD; Li J; Lu X
    BMC Cancer; 2018 Dec; 18(1):1256. PubMed ID: 30558666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100 family members: potential therapeutic target in patients with hepatocellular carcinoma: A STROBE study.
    Zhang C; Yao R; Chen J; Zou Q; Zeng L
    Medicine (Baltimore); 2021 Jan; 100(3):e24135. PubMed ID: 33546025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the expression and prognosis for S100 in human ovarian cancer: A STROBE study.
    Xu HY; Song HM; Zhou Q
    Medicine (Baltimore); 2020 Nov; 99(47):e22777. PubMed ID: 33217795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.
    Li X; Qiu N; Li Q
    Front Genet; 2021; 12():758725. PubMed ID: 34804125
    [No Abstract]   [Full Text] [Related]  

  • 8. An Integrated Bioinformatic Analysis of the S100 Gene Family for the Prognosis of Colorectal Cancer.
    Zeng ML; Zhu XJ; Liu J; Shi PC; Kang YL; Lin Z; Cao YP
    Biomed Res Int; 2020; 2020():4746929. PubMed ID: 33294444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct prognostic roles of S100 mRNA expression in gastric cancer.
    Wang C; Luo J; Rong J; He S; Zhang L; Zheng F
    Pathol Res Pract; 2019 Jan; 215(1):127-136. PubMed ID: 30414696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of S100A6/S100A11 in T-Cell Immune Regulatory in HCC Revealed by Single Cell RNA-seq.
    Zhou R; Pei B; Li X; Zhang X
    Technol Cancer Res Treat; 2024; 23():15330338241252610. PubMed ID: 38766816
    [No Abstract]   [Full Text] [Related]  

  • 11. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma.
    Zhou X; Dou M; Liu Z; Jiao D; Li Z; Chen J; Li J; Yao Y; Li L; Li Y; Han X
    J Immunol Res; 2021; 2021():5518908. PubMed ID: 34426790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
    Jiang W; Wu T; Shi X; Xu J
    Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma.
    Zhang Z; Li J; He T; Ouyang Y; Huang Y; Liu Q; Wang P; Ding J
    Cancer Sci; 2019 Sep; 110(9):2905-2923. PubMed ID: 31335995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma.
    Mei J; Wang H; Wang R; Pan J; Liu C; Xu J
    Biomed Res Int; 2020; 2020():5751939. PubMed ID: 32258128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of mRNA expression of phospholipase C β family genes in hepatitis B virus‑associated hepatocellular carcinoma.
    Wang X; Huang K; Zeng X; Liu Z; Liao X; Yang C; Yu T; Han C; Zhu G; Qin W; Peng T
    Oncol Rep; 2019 May; 41(5):2855-2875. PubMed ID: 30896816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of S100 family mRNA expression in ovarian cancer.
    Ma N; Zhu L; Yang L; Cui Y; Zhan Y
    Cancer Biomark; 2019; 25(1):67-78. PubMed ID: 31033462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.